The silver lining of induced pluripotent stem cell variation

Area of Science:

• Stem cell biology
• Genomics and epigenomics
• Cellular reprogramming

Background:

• Induced pluripotent stem cells (iPSCs) are crucial for regenerative medicine.
• Variability among iPSC lines necessitates thorough evaluation for clinical applications.
• Both genetic diversity and acquired alterations contribute to iPSC heterogeneity.

Purpose of the Study:

• To review studies on iPSC line variability and its impact on differentiation capacity.
• To discuss strategies for evaluating and minimizing genomic and epigenomic alterations in iPSCs.
• To highlight findings on DNA methylation patterns correlating with hematopoietic differentiation capacity.

Main Methods:

• Review of existing literature on iPSC differentiation and variability.
• Analysis of studies investigating genomic and epigenomic alterations in iPSCs.
• Focus on a specific study comparing hematopoietic differentiation capacity and DNA methylation in iPSC lines.

Main Results:

• iPSC line variability arises from genetic diversity and genomic/epigenomic alterations.
• Aberrant DNA methylations were correlated with differential hematopoietic maturation capacity in iPSCs.
• Technical and culture-induced noise can introduce further variation.

Conclusions:

• iPSC variation presents challenges but can be leveraged for predicting line performance.
• Strategies to minimize technical noise are essential for safe clinical translation.
• Understanding and utilizing iPSC heterogeneity can optimize cell selection for specific applications.